DexCom (NASDAQ:DXCM) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $0.68,…
DexCom (NASDAQ:DXCM) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.68, beating the consensus estimate of $0.65 by $0.03 per share. Revenue came in at $1.3B, beating the estimate of $1.3B.
DexCom's stock moved following the earnings release. The stock currently trades at $70.02 with a market capitalization of $27.0B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · DXCM
$90.82
Down: -$0.65 · -0.71%
Live quote updated
Keep reading
analyst ·
earnings ·
institutional ·
institutional ·
